These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2889658)

  • 1. Antipsychotic agents of the future.
    Gershon S
    Hosp Community Psychiatry; 1987 Nov; 38(11):1141. PubMed ID: 2889658
    [No Abstract]   [Full Text] [Related]  

  • 2. Now we understand antipsychotics?
    Lancet; 1990 Nov; 336(8725):1222-3. PubMed ID: 1978074
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for pharmacotherapy of schizophrenia.
    Pickar D
    Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine and schizophrenia.
    Crow TJ; Deakin JF; Johnstone EC; Longden A
    Lancet; 1976 Nov; 2(7993):1027. PubMed ID: 62251
    [No Abstract]   [Full Text] [Related]  

  • 5. Collaborated basic bio-medical research.
    Farooq S
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):499-500. PubMed ID: 16899174
    [No Abstract]   [Full Text] [Related]  

  • 6. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T; Cookson J
    Neuropharmacology; 1983 Apr; 22(4):539-41. PubMed ID: 6134252
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical assessment of dopamine receptor blockade.
    Sedvall G; Bjerkenstedt L; Lindström L; Wode-Helgodt B
    Life Sci; 1978 Aug; 23(5):425-9. PubMed ID: 29184
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treatment of schizophrenia.
    Silverstone T
    N Z Med J; 1994 Apr; 107(976):145-6. PubMed ID: 7909363
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
    Harrison PJ
    Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of action of anti-psychotic drugs.
    Strange PG
    Biochem Soc Trans; 1999 Feb; 27(2):175-8. PubMed ID: 10093729
    [No Abstract]   [Full Text] [Related]  

  • 12. Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
    Buckley PF
    J Clin Psychiatry; 2007; 68 Suppl 6():5-9. PubMed ID: 17650053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology of schizophrenia: neurochemical aspects].
    de las Cuevas Castresana C; González de Rivera JL
    Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
    [No Abstract]   [Full Text] [Related]  

  • 14. New antipsychotic agents and the future.
    Mackay AV
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):51-3. PubMed ID: 2858482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How do clozapine and co. work? Pharmacologic mechanisms of atypical neuroleptics].
    Müller WE
    Pharm Unserer Zeit; 2002; 31(6):537-45. PubMed ID: 12481511
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic drugs and the sigma receptor.
    Hoffman DW
    Am J Psychiatry; 1990 Aug; 147(8):1093-4. PubMed ID: 1973876
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 18. Practical issues in clinical research of schizophrenia.
    Brunello N; Judd LL; Langer SZ; Mendlewicz J; Racagni G
    Neuropsychobiology; 1997; 35(2):57-60. PubMed ID: 9097292
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia.
    J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine receptors, antipsychotic action and schizophrenia.
    Reynolds GP
    J Psychopharmacol; 1999; 13(2):202-3. PubMed ID: 10475731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.